the year america collectively decided everyone needed a little more dopamine and a lot more adderall.
means a sharp, sustained rise in prescriptions for adhd stimulant medications like adderall and vyvanse, especially after 2020.
from traces to a convergence around 2020: pandemic-driven telehealth made diagnosis a video call away, remote work exposed attention struggles that offices used to mask, and social media normalized adult adhd talk into a viral self-diagnosis pipeline.
adderall shortage 2022 — fda declared official shortage as demand outpaced manufacturing
cerebral inc — telehealth startup investigated for overprescribing stimulants in 2022
done health — another telehealth firm raided by dea over stimulant scripts
dea prescribing rules — pandemic flexibility extended repeatedly through 2024 amid backlash